Skip to main content

Table 4 Antimicrobial susceptibility testing results in blood and CSF of A. baumannii, P. aeruginosa, E. coli, K. pneumoniae, Enterobacter spp., E. faecium, S. aureus, S. pneumoniae and H. influenzae; in stool for Salmonella spp. and Shigella spp. of 13 hospitals in VINARES 2016–2017 project. Denominators and numerators are the numbers of tested and resistant isolates respectively. Corresponding resistant percentages are in brackets

From: Antimicrobial susceptibility testing results from 13 hospitals in Viet Nam: VINARES 2016–2017

  E. coli (N = 1535) K. pneumoniae (N = 482) A. baumannii (N = 187) P. aeruginosa (N = 142) Enterobacter spp. (N = 77) Shigella spp. (N = 37)** Salmonella spp. (N = 32)** H. influenzae (N = 12)
Carbapenem 116/1483 (8%) 109/476 (23%) 110/183 (60%) 54/139 (39%) 20/77 (26%) 1/14 (7%) 0/19 (0%) 0/11 (0%)
Aminoglycosides 637/1471 (43%) 195/470 (41%) 107/185 (58%) 48/138 (35%) 35/75 (47%)    
Fluoroquinolones 953/1475 (65%) 177/459 (39%) 96/182 (53%) 37/138 (27%) 24/76 (32%) 4/31 (13%) 3/27 (11%) 0/9 (0%)
Cephalosporins 931/1402 (66%) 221/471 (47%) 118/178 (66%) 47/120 (39%) 37/66 (56%) 7/21 (33%) 4/28 (14%) 0/11 (0%)
Macrolides    1/1 (100%)    2/3 (67%) 1/5 (20%) 0/4 (0%)
SXT 935/1377 (68%) 215/454 (47%)   74/82 (90%) 29/57 (51%) 31/34 (91%) 6/30 (20%) 5/8 (62%)
AMC 180/577 (31%) 112/285 (39%)    26/32 (81%)    1/5 (20%)
Ampicillin 928/1028 (90%) 278/287 (97%)    21/23 (91%) 23/33 (70%) 14/31 (45%) 7/8 (88%)
TCC 169/356 (47%) 115/195 (59%)   46/110 (42%) 14/45 (31%)    
  1. SXT: Trimethoprim/Sulfamethoxazole; AMC: amoxicillin clavulanic acid; TCC: Ticarcillin/Clavulanic Acid; *: Resistant and Intermediate